Compliance with FDA recommendations for pemoline.
Sarkis
Elias H
EH
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D002665:Child Psychiatry; D019983:Guideline Adherence; D006801:Humans; D010389:Pemoline / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000697:Central Nervous System Stimulants; D010389:Pemoline